Finance

Lists
SENS:NASDAQ
Senseonics Holdings Inc
$9.88
-0.80%
(-0.080) 1D
$9.95
+0.70% (+0.069)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SENS...
Open
$10.04
High
$10.09
Low
$9.78
Mkt. cap
522.40M
Avg. vol.
696.24K
Volume
705.95K
52-wk high
$11.58
52-wk low
$4.79
EPS
-$2.24
Beta
1.02
Shares outstanding
52.87M
No. of employees
130
Open
$10.04
High
$10.09
Low
$9.78
Mkt. cap
522.40M
Avg. vol.
696.24K
Volume
705.95K
52-wk high
$11.58
52-wk low
$4.79
EPS
-$2.24
Beta
1.02
Shares outstanding
52.87M
No. of employees
130
News stories
From web sources and news partners
About Senseonics Holdings Inc
CEOTimothy T. Goodnow
Employees130
Founded1996
Headquarters-
SectorMedical device
Websitesenseonics.com
Analyst ratings
Based on 5 analysts giving stock ratings to SENS in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SENS in the last 3 months.
Highest
Current $9.88
$18.00 (+82.19%)
Average
$14.75 (+49.29%)
Lowest
$12.00 (+21.46%)
Analyst
Recommendation
Action
Price target
Projected
Date
Sean Lee CFA
H.C. Wainwright
Buy
Reiterated
$14.00
+41.7%
10/01/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$15.00
+51.8%
09/28/2026
Ben Haynor
Lake Street
Buy
Reiterated
$12.00
+21.5%
08/07/2026
Marie Thibault
BTIG
Hold
Maintained
-
-
08/07/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$18.00
+82.2%
07/15/2026
Jonathan Block
Stifel Nicolaus
Hold
Maintained
$8.00
-19%
05/11/2026
Matt Miksic
Barclays
Buy
Maintained
$31.00
+213.8%
05/11/2026
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.63 / -$0.61
-3.85%miss
Revenue / Est. (USD)
14.48M / 12.81M
+13.09%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
8.10M
14.26M
11.71M
14.48M
Cost of goods sold
4.63M
6.59M
4.77M
5.92M
Cost of revenue
4.63M
6.59M
4.77M
5.92M
Research and development expenses
7.76M
8.82M
8.61M
11.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.31M
19.78M
30.18M
32.91M
Operating expense
23.07M
28.59M
38.79M
44.55M
Total operating expenses
27.70M
35.18M
43.56M
50.47M
Operating income
-19.60M
-20.92M
-31.85M
-35.99M
Other non operating income
6.00K
-6.00K
-37.00K
-149.00K
EBT including unusual items
-19.53M
-20.82M
-32.33M
-36.70M
EBT excluding unusual items
-19.53M
-20.82M
-32.33M
-36.70M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-19.53M
-20.82M
-32.33M
-36.70M
Net profit margin
-241.26%
-146.06%
-276.09%
-253.44%
Earnings per share
-0.43
-0.46
-0.71
-0.63
Interest and investment income
1.24M
1.31M
742.00K
1.03M
Interest expense
-1.17M
-1.21M
-1.19M
-1.60M
Net interest expenses
65.00K
108.00K
-450.00K
-568.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.22M
-20.54M
-31.30M
-35.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps